A team of researchers from Carnegie Mellon University's Department of Biological Sciences and the University of Texas ...

Both vibostolimab and favezelimab have had disappointing runs leading up to their termination, sustaining several late-stage ...

VANCOUVER, Washington, Dec. 17, 2024 (GLOBE NEWSWIRE) -- ...

Predictive cancer diagnostics company Rhythm Biosciences (ASX:RHY) is ending 2024 on a high reporting it has attained all key ...

Through its collaboration with Nvidia, Genesis is working to accelerate development of its AI platform, Genesis Exploration ...

Dear Shareholders, As I look back on 2024, during which CytoDyn Inc. ("CytoDyn" or the "Company") achieved multiple crucial milestones ...

Pathways Early Education Center of Immokalee, which provides affordable child care, plans to raise more than $2 million, so ...

Clarity Pharmaceuticals (ASX:CU6) has developed a novel radiopharmaceutical called "SAR-bisFAP", a product that could be used ...